natgillin/translations-raw huggingface dataset:
Zbiranje in skupna raba dejstev o učinkovitih strategijah, politikah in ukrepih bosta pomagala zagotoviti podporo med vladami in različnimi sektorji.
Collecting and sharing evidence on effective strategies, policies and actions will help engage support across government and different sectors.
Bistveno je, da se zmanjšanje neenakosti na področju zdravja obravnava kot nujna prednostna naloga na vseh ravneh oblikovanja politik, s čimer se uresničuje pristop „zdravje v vseh politikah“ in zagotavljajo učinkovite ocene učinka, ki upoštevajo rezultate glede na pravičnost na področju zdravja.
It is essential that the reduction of health inequalities is considered an essential priority, at all levels of policy making, thereby pursuing a Health in All Policies Approach (HiAP) and ensuring effective impact assessments that take health equity outcomes into account.
Pripravljavka mnenja: Emma McClarkin
Rapporteur: Emma McClarkin
7. spodbuja države članice, naj v obmejnih regijah razvijejo partnerstva, da bi si delile stroške infrastrukture in dela, hkrati pa bi omejile prostorske neenakosti na področju zdravja, zlasti kar zadeva enak dostop do najsodobnejše opreme;
Encourages Member States to develop partnerships in border regions in order to share costs of infrastructure and personnel, while limiting spatial inequalities with regard to health, particularly for equal access to state-of-the-art equipment;
12. spodbuja države članice, naj povečajo uporabo kakovostnih generičnih zdravil in se čim bolje pogajajo za cene zdravil, po potrebi z meddržavnim sodelovanjem, da bi najbolj prikrajšanim skupinam omogočile dostop do kakovostnega zdravljenja;
Encourages Member States to increase the use of quality generic medicines and to negotiate as best possible, if appropriate in cooperation between States, the prices of medicines so as to enable the most disadvantaged groups to gain access to quality treatments;
16. poziva Komisijo, naj preuči učinke sklepov na podlagi nacionalnih in regionalnih ocen učinkovitosti zdravil in medicinskih pripomočkov na notranjem trgu, zlasti dostopa za paciente, inovacije novih izdelkov in medicinske prakse, ki sodijo med pomembnejše elemente enakosti na področju zdravja;
Asks the Commission to study the effects of decisions based on national and regional assessments of the effectiveness of medicines and medical devices on the internal market, including patient access, innovation in new products and medical practices, which are some of the main elements effecting health equality;
18. meni, da bi bilo treba pri izvajanju direktive o pravicah pacientov v čezmejnem zdravstvenem varstvu (2008/0142 (COD)) opraviti ocene učinkov, da bi čim bolj učinkovito izmerili njene posledice v boju proti neenakostim na področju zdravja ter zagotovili ohranitev javnega zdravja in zagotavljanja varnosti pacientov, zlasti kar zadeva geografsko porazdelitev človeških in materialnih zdravstvenih virov;
Considers that the implementation of the Directive on Patients' Rights in Cross-Border Healthcare (2008/0142 (COD)) should be followed by impact assessments in order to measure as effectively as possible its consequences in combating health inequalities and to ensure that it maintains public protection and safeguards patient safety, particularly in terms of the geographical allocation of medical resources, both human and material;
21. poudarja, da je pomanjkanje zdravstvenih delavcev na nekaterih geografskih območjih vzrok neenakosti na področju zdravja; zato spodbuja njihovo mobilnost v Evropski uniji glede na dejanske potrebe prebivalstva;
Stresses that the existence of geographical areas which are poor in healthcare professionals is one of the causes of health inequalities; advocates therefore mobility of healthcare professionals within the European Union in accordance with the genuine needs of the population;
24. poudarja, da neenakosti na področju zdravja v EU ne bodo odpravljene brez skupne in splošne strategije za evropske zdravstvene delavce, vključno usklajene politike za upravljanje virov, izobraževanje in usposabljanje, minimalno kakovost in varnostne ukrepe ter registracijo strokovnjakov;
Underlines that health inequalities in the Union will not be overcome without a common and overall strategy for the European health workforce, including coordinated policies for resource management, education and training, minimum quality and safety standards, and registration of professionals;
26. poziva Komisijo, naj v svojem naslednjem zakonodajnem predlogu o poklicnih kvalifikacijah okrepi mehanizem za priznavanje kvalifikacij v državah članicah;
Urges the Commission, in its forthcoming legislative proposal on professional qualifications, to move towards a reinforced mechanism for the recognition of qualifications in the Member States;
33. poziva Komisijo, skupaj z državami članicami, naj začne kampanjo v šolah za spodbujanje zdravja in zdravstvene vzgoje, še posebej pa zdravega načina življenja, skupaj s preventivnimi programi in programi za zgodnje odkrivanje bolezni;
Urges the Commission, together with the Member States, to launch campaigns in schools to promote health and health education, and healthy lifestyles in particular, together with prevention and screening programmes geared to specific groups;
Regina Bastos, Cornelis de Jong, Frank Engel, Ashley Fox, Jean-Paul Gauzès, Liem Hoang Ngoc, María Irigoyen Pérez, Othmar Karas, Lena Kolarska-Bobińska, Constance Le Grip, Emma McClarkin, Antonija Prvanova (Antonyia Parvanova), Sylvana Rapti, Marek Siwiec
Regina Bastos, Cornelis de Jong, Frank Engel, Ashley Fox, Jean-Paul Gauzès, Liem Hoang Ngoc, María Irigoyen Pérez, Othmar Karas, Lena Kolarska-Bobińska, Constance Le Grip, Emma McClarkin, Antonyia Parvanova, Sylvana Rapti, Marek Siwiec
o zmanjšanju neenakosti na področju zdravja v EU
on reducing health inequalities in the European Union
Pripravljavka mnenja: Sylvie Guillaume
Rapporteur: Sylvie Guillaume
– ob upoštevanju člena 35 Listine Evropske unije o temeljnih pravicah,
– having regard to Article 35 of the Charter of Fundamental Rights of the European Union ,
– ob upoštevanju Sklepa št. 1350/2007/ES Evropskega parlamenta in Sveta z dne 23. oktobra 2007 o uvedbi drugega programa ukrepov Skupnosti na področju zdravja (2003–2013)
– having regard to Decision No 1350/2007/EC of the European Parliament and of the Council of 23 October 2007 establishing a second programme of Community action in the field of health (2008-2013)
UL L 301, 20. november 2007, str.
OJ L 301, 20.11.2007, p.
– ob upoštevanju člena 168 Pogodbe o delovanju Evropske unije, ki se nanaša na zdravstvene politike,
– having regard to Article 168 of the Treaty on the Functioning of the European Union, on health policies,
– ob upoštevanju sporočila Komisije z naslovom Solidarnost na področju zdravja: zmanjšanje neenakosti na področju zdravja v EU
– having regard to the Commission communication entitled ‘Solidarity in health: reducing health inequalities in the EU’
– ob upoštevanju člena 23 Listine o temeljnih pravicah, ki se nanaša na enakost med spoloma na vseh področjih,
– having regard to Article 23 of the Charter of Fundamental Rights relating to equality between men and women in all areas,
A. ker obstajajo med moškimi in ženskami biološke, socialno-ekonomske in kulturne razlike, s tem pa tudi razlike v njihovih zdravstvenih tveganjih, potrebah in težavah,
A. conscious of the biological, socio-economic and cultural differences between men and women, and the resulting differences in their respective health concerns, needs and problems,
B. ker se neenakosti v zdravju pogosteje pojavljajo pri ranljivih osebah, ki so še posebej odvisne od dostopnega in kakovostnega javnega zdravstva;
B. whereas health inequalities appear more often among vulnerable people who are especially dependent on affordable public healthcare of good quality,
C. ker se ženske pogosto znajdejo v negotovem položaju zaradi spola, načina življenja, vere, starosti, družbenega statusa in plačilne sposobnosti,
C. whereas women often find themselves in precarious situations linked to their gender, way of life, religion, age, social status and financial solvency,
D. ker neenakosti glede na spol in starost v biomedicinskih raziskavah ter slaba zastopanost žensk pri kliničnih študijah škodujejo oskrbi bolnikov;
D. whereas gender and age inequalities in biomedical research and under-representation of women in clinical trials undermine patient care,
E. ker so ženske na splošno, starejše ženske in mlada dekleta nesorazmerno zastopane v najranljivejših družbenih skupinah, ovire pri dostopu do sistema zdravstva pa lahko še povečajo njihovo ranljivost in ogrozijo njihove zdravstvene rezultate;
E. whereas women generally, elderly women and young girls are disproportionately represented in society’s most vulnerable groups, and whereas barriers in access to the healthcare system may further exacerbate their vulnerable status and compromise their health outcomes,
F. ker se pojav uporabe tobaka pri ženskah, predvsem mladih, hitro povečuje, kar uničujoče vpliva na njihovo zdravje; ker je negativni učinek kajenja pri ženskah še večji v kombinaciji z drugimi pomanjkljivostmi;
F. whereas the incidence of tobacco use among women, particularly young women, is rapidly rising with devastating consequences for their future health; and whereas, in the case of women, smoking is aggravated by multiple disadvantage,
G. ker je nasilje nad ženskami razširjeno v vseh državah in družbenih razredih ter ima hude posledice na telesno in čustveno zdravje žensk in otrok,
G. whereas violence against women is a widespread phenomenon in all countries and among all social classes and has a dramatic effect on the physical and emotional health of women and children,
H. ker ženske na splošno živijo dlje kot moški, vendar jih v zadnjih letih življenja pogosteje pestijo kronične bolezni, invalidnost in izguba kakovosti življenja,
H. whereas women usually live longer than men, but suffer more from chronic diseases, disability and loss of quality of life in later years,
I. ker pravičen dostop do zdravstvenih storitev zmanjšuje neenakosti na področju zdravja in ker zanj na splošno velja, da vsem ljudem, ne glede na njihove dohodke, zagotavlja enak dostop do zdravljenja,
I. whereas fair access to health services reduces health inequalities and is generally understood as equal access to treatment for all persons regardless of their income,
J. ker v več državah članicah EU
J. whereas in several EU Member States
Organizacija Zdravniki sveta, Evropski opazovalni urad za dostop do zdravstvenega varstva: poročilo raziskave z naslovom Dostop oseb, ki nimajo dovoljenja za bivanje, do zdravstvenega varstva za leto 2007 in za leto 2009; HUMA: poročilo z naslovom Dostop oseb, ki nimajo dovoljenja za bivanje, in beguncev do zdravstvenega varstva v desetih državah EU – zakonodaja in praksa, 2009. ni vsem zagotovljen pravičen dostop do zdravstvenih storitev, tako v praksi kot po zakonu, kar zlasti velja za osebe, ki nimajo dovoljenja za bivanje,
Doctors of the World, European Observatory on Access to Health Care, Undocumented migrants’ access to health care, survey reports for 2007 and 2009; HUMA, Law and practice, Access to health care for undocumented migrants and asylum seekers in 10 EU countries, 2009. fair access to health services is not guaranteed for all, in practice or by law, especially for undocumented migrants,
K. ker je neplodnost bolezen, ki jo priznava Svetovna zdravstvena organizacija in ki močno vpliva na zdravje žensk; ker je raziskava o nacionalni ozaveščenosti v Veliki Britaniji pokazala, da je več kot 94 % neplodnih žensk tudi depresivnih,
K. whereas infertility is a medical condition recognised by the World Health Organisation which has a particular impact on women’s health, and whereas the UK National Awareness Survey has shown that over 94% of women suffering from infertility also suffer from forms of depression,
L. ker so med državami članicami velike razlike na področju dostopa do zdravljenja neplodnosti;
L. whereas there is great inconsistency between Member States in terms of access to fertility treatment,
2. poziva EU in države članice, naj posebno pozornost namenijo invalidnim in starejšim ženskam, da bi jim zagotovili pravico do dostopa do zdravstvenih storitev in kakovostne nege, ne glede na osebne ekonomske okoliščine;
Calls on the EU and Member States to pay attention to women with disabilities and elderly women, with a view to guaranteeing the right of access to health services and quality care, regardless of personal economic circumstances;
9. poziva države članice, naj spodbujajo in podpirajo medicinske in farmacevtske raziskave bolezni, ki večinoma prizadenejo ženske, in sicer v vseh fazah njihovega življenja, ne le v njihovi rodni dobi;
Calls on the Member States to encourage and support medical and pharmaceutical research into illnesses that primarily affect women, with reference to all phases of their lives and not only their reproductive years;
18. poziva države članice, naj upoštevajo posebne potrebe priseljenk v zvezi z varovanjem zdravja, zlasti glede storitev jezikovne mediacije, ki jih zagotovijo zdravstveni sistemi; sistemi bi morali razviti usposabljanje, ki bi zdravnikom in drugim strokovnjakom omogočalo sprejetje medkulturnega pristopa, ki bi temeljil na prepoznavanju in spoštovanju raznolikosti in občutljivosti oseb z drugih geografskih območij; prednost je treba dati tudi ukrepom in kampanjam obveščanja za boj proti pohabljanju ženskih spolnih organov, vključno s strogimi kaznimi za tiste, ki jih izvajajo;
Calls on the Member States to take account of the specific health protection needs of immigrant women, with particular reference to the guaranteed provision by health systems of appropriate language mediation services; those systems should develop training initiatives enabling doctors and other professionals to adopt an intercultural approach based on recognition of, and respect for, diversity and the sensitivities of people from different geographical regions; priority must also be given to measures and information campaigns to combat female genital mutilation, including severe penalties for those who practise it;
21. meni, da morajo države članice sprejeti ukrepe, da bodo vsem ženskam (tudi na primer migrantkam, begunkam in ženskam na podeželju) zagotovile dostop do zdravstvenih storitev, ne glede na njihov finančni, družbeni, jezikovni, zemljepisni, kulturni ali pravni status; v zvezi s tem poziva države članice, naj sprejmejo ukrepe za regulacijo poklica kulturnega mediatorja sistemov javnega zdravstva;
Considers that the EU and the Members States must take measures to ensure access to healthcare services for all women (including, for example, women migrants, refugees and women in rural areas) regardless of their age or their financial, social, linguistic, geographical, cultural or legal status; in this connection, calls on the Member States to take steps to regulate the profession of cultural mediator within public health systems;
Izaskun Bilbao Barandica, Vilija Blinkevičiūtė, Sylvie Guillaume, Norica Nicolai, Antigoni Papadopulu (Antigoni Papadopoulou), Sirpa Pietikäinen
Izaskun Bilbao Barandica, Vilija Blinkevičiūtė, Sylvie Guillaume, Norica Nicolai, Antigoni Papadopoulou, Sirpa Pietikäinen
o reviziji direktive o splošni varnosti proizvodov in nadzoru trga
on the revision of the General Product Safety Directive and market surveillance
MNENJE Odbora za mednarodno trgovino ........................................................14
OPINION of the Committee on International Trade ......................................14
– ob upoštevanju Direktive 2001/95/ES Evropskega parlamenta in Sveta z dne 3. decembra 2001 o splošni varnosti proizvodov
– having regard to Directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on general product safety
– ob upoštevanju Uredbe (ES) št. 765/2008 Evropskega Parlamenta in Sveta z dne 9. julija 2008 o določitvi zahtev za akreditacijo in nadzor trga v zvezi s trženjem proizvodov ter razveljavitvi Uredbe (EGS) št. 339/93
– having regard to Regulation (EC) No 765/2008 of the European Parliament and of the Council of 9 July 2008 setting out the requirements for accreditation and market surveillance relating to the marketing of products and repealing Regulation (EEC) No 339/93
– ob upoštevanju Sklepa Komisije z dne 16. decembra 2009 o smernicah za upravljanje hitrega informacijskega sistema Skupnosti (RAPEX) iz člena 12 in postopka obveščanja iz člena 11 Direktive 2001/95/ES (direktiva o splošni varnosti proizvodov) (2010/15/ES)
– having regard to the Commission Decision of 16 December 2009 laying down guidelines for the management of the Community Rapid Information System ‘RAPEX’ established under Article 12, and of the notification procedure established under Article 11, of Directive 2001/95/EC (the General Product Safety Directive) (2010/15/EC)
UL L 22, 26.1.2010, str.
OJ L 22, 26.1.2010, p.
– ob upoštevanju poročila Komisije Evropskemu parlamentu in Svetu o izvajanju Direktive 2001/95/ES Evropskega parlamenta in Sveta z dne 3. decembra 2001 o splošni varnosti proizvodov ( KOM(2008)0905 ),
– having regard to the Report from the Commission to the European Parliament and to the Council on implementation of Directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on general product safety, ( COM(2008)0905 ),
– ob upoštevanju delovnega dokumenta Komisije z naslovom Revizija direktive o splošni varnosti proizvodov: povzetek predvidenih ukrepov, ki ga je 18. maja 2010 pripravil generalni direktorat za zdravje in varstvo potrošnikov,
– having regard to the Commission Working Document entitled ‘Revision of the General Product Safety Directive: Summary envisaged actions’, DG Health and Consumers, 18 May 2010,
– ob upoštevanju programa z naslovom Usklajevanje z novim zakonodajnim okvirom (Sklep 768/2008), ki ga je 15. aprila 2010 pripravil generalni direktorat za podjetništvo in industrijo,
– having regard to the Roadmap entitled ‘Alignment to the New Legislative Framework (Decision 768/2008)’, DG Enterprise and Industry, 15 April 2010,
– ob upoštevanju programa z naslovom Revizija Direktive 2001/95/EGS Evropskega parlamenta in Sveta z dne 3. decembra 2001 o splošni varnosti proizvodov, ki ga je 25. marca 2010 pripravil generalni direktorat za zdravje in varstvo potrošnikov,
– having regard to the Roadmap entitled ‘Review of Directive 2001/95/EC of the European Parliament and of the Council of 3 December 2001 on general product safety (GPSD)’, DG Health and Consumers, 25 March 2010,
– ob upoštevanju delovnega dokumenta Komisije o razmerju med Direktivo o splošni varnosti proizvodov 2001/95/ES in določbami o nadzoru trga iz Uredbe (ES) št. 765/2008, ki ga je 2. marca 2010 pripravil generalni direktorat za zdravje in varstvo potrošnikov,
– having regard to the Commission Working Paper on the relationship between the General Products Safety Directive 2001/95/EC and the market surveillance provisions of Regulation (EC) No 765/2008, DG Health and Consumers, 2 March 2010,
– ob upoštevanju delovnega dokumenta Komisije z naslovom Revizija direktive o splošni varnosti proizvodov: določitev ključnih vprašanj, ki ga je 15. septembra 2009 pripravil generalni direktorat za zdravje in varstvo potrošnikov,
– having regard to the Commission Working Document entitled ‘Revision of the General Product Safety Directive: Identification of the Key Issues’, DG Health and Consumers, 15 September 2009,
– ob upoštevanju informativnega dokumenta o nadzoru trga v državah članicah, ki ga je naročil odbor IMCO in je bil objavljen oktobra 2009,
– having regard to the briefing paper commissioned by the IMCO Committee on Market Surveillance in the Member States, published in October 2009,
– ob upoštevanju informativnega dokumenta o reviziji direktive o splošni varnosti proizvodov in nadzoru trga, ki ga je naročil odbor IMCO in je bil objavljen septembra 2010,
– having regard to the briefing paper commissioned by the IMCO Committee on the Revision of the General Product Safety Directive (GPSD) and Market Surveillance, published in September 2010,
– ob upoštevanju delavnice o reviziji direktive o splošni varnosti proizvodov in nadzoru trga, ki je potekala 30. septembra 2010,
– having regard to the workshop on the Revision of the General Product Safety Directive and Market Surveillance held on 30 September 2010,
– ob upoštevanju tristranskega vrha EU-ZDA-Kitajska v Šanghaju 25. in 26. oktobra 2010,
– having regard to the EU-US-China trilateral Summit held in Shanghai on 25-26 October 2010,
– ob upoštevanju poročila Odbora za notranji trg in varstvo potrošnikov ter mnenj Odbora za mednarodno trgovino in Odbora za industrijo, raziskave in energetiko ( A7-0033/2011 ),
– having regard to the report of the Committee on the Internal Market and Consumer Protection and the opinions of the Committee on International Trade and the Committee on Industry, Research and Energy ( A7-0033/2011 ),
A. ker je nujno treba zagotoviti varnost vseh proizvodov, danih na trg EU, da bi med drugim zagotovili visoko stopnjo varstva potrošnikov,
A. whereas it is essential to ensure that all products placed on the EU market are safe so as to guarantee a high level of protection for consumers among others,
B. ker je bil julija 2008 sprejet nov zakonodajni okvir, od 1. januarja 2010 pa se uporablja nova Uredba (ES) št. 765/2008 o nadzoru trga,
B. whereas the New Legislative Framework (hereinafter the NLF) was adopted in July 2008, and Regulation (EC) No 765/2008 on market surveillance has been applicable as of 1 January 2010,
C. ker je treba Direktivo 2001/95/ES o splošni varnosti proizvodov (v nadaljevanju: DSVP), ki na ravni Skupnosti določa varnostne zahteve za proizvode za potrošnike, pregledati in uskladiti z novim zakonodajnim okvirom, in sicer s povezovanjem, zlasti z uredbo o nadzoru trga,
C. whereas the General Product Safety Directive 2001/95/EC (hereinafter the GPSD), which establishes at Community level general safety requirements for consumer products, has to be reviewed and brought into conformity with the NLF through integration, in particular with the Regulation on market surveillance,
D. ker zakonodajni okvir o varnosti proizvodov in nadzoru trga sestavljajo tri plasti zakonskih aktov (DSVP, nov zakonodajni okvir in direktive o uskladitvi posameznih sektorjev), kar povzroča negotovost in zmedo na notranjem trgu,
D. whereas the product safety and market surveillance legislative framework consists of three layers of legal acts (GPSD, NLF and sector-specific harmonisation directives), which leads to uncertainties and confusion in the internal market,
E. ker se stopnja nadzora trga precej razlikuje med državami članicami in ker številne države članice niso določile potrebnih virov za učinkovit nadzor trga in različno tolmačijo „proizvode, ki pomenijo resno nevarnost“, kar lahko ustvari ovire za prosti pretok blaga, izkrivlja konkurenco in ogrozi varnost potrošnikov na notranjem trgu,
E. whereas the level of market surveillance differs considerably among Member States and a number of them fail to designate necessary resources for efficient market surveillance and interpret ‘products posing serious risk’ differently, which can create barriers to the free movement of goods; disturb competition and jeopardise consumers’ safety within the internal market,
F. ker so sodelovanje med organi za nadzor trga in skupni ukrepi za nadzor trga nujni in bi jih bilo treba še okrepiti ter jim nameniti sredstva,
F. whereas cooperation among market surveillance authorities and joint market surveillance actions are essential and should therefore be strengthened further and resources delegated thereto,
1. je prepričan, da sedanji zakonodajni okvir za nadzor trga ne zagotavlja zadostne skladnosti ter ga je zato treba pregledati in nadalje uskladiti;
Believes that the current legislative framework for market surveillance does not provide enough coherence and should therefore be reviewed and further coordinated;